Appendix E - National Coverage Determinations Manual / New_Topic6

Why This Topic Matters

Coverage policy determines whether a service or drug may be reimbursed by Medicare, so this NCD is important for coding, billing, and compliance in prostate cancer care.

Article Sections

1. A. General

   Provides background on prostate cancer treatment and the clinical context for the policy discussion. It introduces the drug and the broader therapeutic setting addressed by the determination.

2. B. Nationally Covered Indications

   Summarizes the circumstances under which Medicare coverage is addressed for this therapy. It also outlines related provider and program participation requirements tied to coverage.

3. C. Nationally Noncovered Indications

   Describes the category of uses not addressed as covered under this determination. It also notes the relationship between this policy and other referenced drug compendia.

4. D. Other

   Contains a brief closing administrative section with no substantive coverage details.